Picture of Collegium Pharmaceutical logo

COLL — Collegium Pharmaceutical News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMid CapSuper Stock

Brief: Collegium Announces Fourth Quarter And Full Year 2022 Preliminary Financial Results

Feb 6 (Reuters) - Collegium Pharmaceutical Inc  COLL.O :
    * COLLEGIUM ANNOUNCES FOURTH QUARTER AND FULL YEAR 2022
PRELIMINARY FINANCIAL RESULTS
    * SEES Q4 PRODUCT REVENUES IN RANGE OF $125.7 MILLION TO
$128.2
MILLION
    * SEES  Q4 ADJUSTED EBITDA IN RANGE OF $71.9 MILLION TO
$74.4
MILLION
    * Q4 EARNINGS PER SHARE VIEW $-0.21, REVENUE VIEW $123.2
MILLION
-- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX5dSqQV 
Further company coverage:  COLL.O 
 ((Reuters.Briefs@thomsonreuters.com))

Recent news on Collegium Pharmaceutical

See all news